CLASS II Device recall · Reported 23 Sep 2020 · FDA Enforcement Report

Elecsys Anti-TPO Assay on cobas e analyzers recalled

Roche Diagnostics Operations is recalling Elecsys Anti-TPO Assay on cobas e analyzers 411, 601, 602, distributed nationwide in the US. The recall was initiated on 20 Aug 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll current and upcoming lots
Quantity recalled11,870 reagent kits

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2981-2020
FDA event ID
86319
Recalling firm
Roche Diagnostics Operations, Indianapolis, IN
Classification
Class II
Status
Terminated
Recall initiated
20 Aug 2020
FDA classified
17 Sep 2020
Reported
23 Sep 2020
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

20 Aug 2020Recall initiated by company
17 Sep 2020Classified by FDA+28 days
23 Sep 2020Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Recent internal verification studies found the current RF interference claim to no longer be met for the assay on the cobas e 411, 601, and 602 analyzers. Therefore, the claim has been updated.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Elecsys Anti-TPO Assay on cobas e analyzers 411, 601, 602, Catalog Number 06368590190

Where it was distributed

US Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Recent internal verification studies found the current RF interference claim to no longer be met for the assay on the cobas e 411, 601, and 602 analyzers. Therefore, the claim has been updated.

Which lots are affected?

All current and upcoming lots

Where was it sold?

US Nationwide

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Roche Diagnostics Operations

All 127

Other Test Kits & Diagnostics recalls

All 2,663